USDA, FDA Sign MOU on Animal Biotechnology RegulationJanuary 20, 2021
The United States Department of Agriculture (USDA) and US Department of Health and Human Services signed the Memorandum of Understanding (MOU) finalizing the joint roles of the USDA and the Food and Drug Administration (FDA) in regulating products derived from animal biotechnology.
The MOU was signed on January 13, 2021, and complements USDA's issuance of an Advanced Notice Proposed Rulemaking (ANPR) on the Movement of Animals Modified or Developed by Genetic Engineering released three weeks prior. The MOU covers the responsibilities of the regulation of "amenable species" intended for agricultural purposes developed using genetic engineering. In it, USDA and FDA will both continue to implement existing laws and Acts when regulating the products. However, new roles are also highlighted such as USDA and FDA working together on a communication plan to explain FDA's role in overseeing animal genetic alterations using a streamlined, risk-based approach. USDA is also set to consult FDA when establishing a review process for the product derived by animal biotechnology.
The USDA explained in a press release that the MOU states that USDA will provide oversight of animals modified or developed through genetic engineering for human food from pre-market reviews to post-market food safety monitoring, while FDA will continue its review of intentional genomic alterations intended not just for agricultural use but for biopharma and non-heritable genetic alterations as well. The MOU intends for the transition of the FDA's pre-existing animal biotechnology regulatory responsibilities to USDA.
Read the MOU's details released by USDA to know more.
You might also like:
- USDA Finalizes SECURE, Eases Up Biotech Regulations
- US Observes National Biotech Month, Launches Joint USDA-FDA-EPA Website for Biotech Regulation
- USDA Revises Biotech Regulations to SECURE Agri Innovations
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- Rush Scientists Develop Potential COVID-19 Drug
News from Around the World
- FAO Promotes Innovation to Maintain Agri-Food Systems During the COVID-19 Pandemic
- Dr. Margaret Karembu Conferred Moran of the Order of the Burning Spear (MBS) by Kenyan President
- Camelina Plants Engineered to Produce Pheromones for Pest Control
- USDA APHIS Deregulates GE Insect Resistant Cotton
- Gene Editing Provides Possible Solution to Citrus Greening Disease
- USDA, FDA Sign MOU on Animal Biotechnology Regulation
- FSANZ Calls for Comment for GM Food Derived from Herbicide Tolerant Canola
- EFSA Publishes Scientific Opinion on Four-Event Stack Maize 1507 × MIR162 × MON810 × NK603
- Scientists Propose to Use Genetic Engineering to Develop Fusarium Wilt-Resistant Bananas
Plant Breeding Innovations
- France: "NBTs are not GMOs"
- Improving Biotic Tolerance in Crop Plants through Gene Editing
Read the latest:
- Crop Biotech Update (August 3, 2022)
- Genome Editing Supplement (July 20, 2022)
- Gene Drive Supplement (July 27, 2022)
Subscribe to CBU: